[1] Cell Line:Senescent Leydig cells Concentration:25 mM Incubation Time:3 days Result:The apoptosis rate increased from 10% to 27%
Nasal administration offers an easy, non-invasive option for consistent use, making it ideal for active individuals focused on recovery, resilience, and performance
Rankin GO, Valentovic MA (2018) Historical perspective of nephrotoxicity
For a 5mg dose: 5,000 / 5,000 x 100 = 100 units -- the full syringe
This therapy does not cause any harmful effects
The FDA plans to consult the Pharmacy Compounding Advisory Committee about BPC-157 on July 23, 2026, so this could change soon